Icosavax Inc

NASDAQ:ICVX   2:16:35 PM EDT
3.90
+0.33 (+9.24%)
Earnings Announcements

Icosavax Reports Third Quarter Financial Results

Published: 11/14/2022 21:41 GMT
Icosavax Inc (ICVX) - Icosavax Reports Third Quarter Financial Results and Provides Corporate Update.
Icosavax Inc- Cash and Cash Equivalents, Restricted Cash, and Short-term Investments of $222.5m at End 3q 2022.
Icosavax Inc - Cash and Cash Equivalents, Restricted Cash, and Short-term Investments of $222.5 Million at End 3q 2022.
Icosavax Inc - Currently Expects Its Cash Balance to Be Sufficient to Fund Operations Through at Least 2024.
Icosavax Inc - Qtrly Loss per Share $0.55.
Revenue is expected to be $0.9 Million
Adjusted EPS is expected to be -$0.71

Next Quarter Revenue Guidance is expected to be $0.5 Million
Next Quarter EPS Guidance is expected to be -$0.65

More details on our Analysts Page.